Sana Biotechnology, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
Sana Biotechnology, Inc. has filed 386 SEC EDGAR filings since 26 Jun 2020

SEC filing history

Showing 151-175 of 386 matching filings.

Per page
25
Current page
7
4

PRIMARY DOCUMENT

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92124

SC 13G/A filing

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-277584

S-3ASR

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92124

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92124

ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2)

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92124

SC 13G/A filing

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-266547

424B5

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-266547

FWP

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-266547

424B5

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92124

SC 13G/A filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jan 2024
Reporting date
05 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .